VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
JYNTThe Joint Corp.
$9.34$133M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

JYNT logoThe Joint Corp.(JYNT)Earnings, Financials & Key Ratios

JYNT•NASDAQ
49.2× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryHealthcare FacilitiesSub-IndustryOutpatient clinics and surgery centers
AboutThe Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.Show more
  • Revenue$55M+5.2%
  • EBITDA$808K-71.5%
  • Net Income$3M+150.2%
  • EPS (Diluted)0.19+148.7%
  • Gross Margin79.55%+2.1%
  • EBITDA Margin1.47%-72.9%
  • Operating Margin-1.65%+54.5%
  • Net Margin5.3%+147.7%
  • ROE16.26%+163.7%

JYNT Key Insights

The Joint Corp. (JYNT) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong Piotroski F-Score: 7/9

✗Weaknesses

  • ✗Profits declining 26.1% over 5 years

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when JYNT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

JYNT Price & Volume

The Joint Corp. (JYNT) stock price & volume — 10-year historical chart

Loading chart...

JYNT Growth Metrics

The Joint Corp. (JYNT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years14.78%
5 Years-1.33%
3 Years-18.46%
TTM221.78%

Profit CAGR

10 Years-
5 Years-26.07%
3 Years66.78%
TTM138.06%

EPS CAGR

10 Years-
5 Years-26.73%
3 Years63.72%
TTM138.3%

Return on Capital

10 Years-7.23%
5 Years1.07%
3 Years-2.23%
Last Year-2.91%

JYNT Recent Earnings

The Joint Corp. (JYNT) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.08+166.7%
$0.03
Rev
$15M+2.2%
$15M
Q2 2026
Mar 12, 2026
Metric
Actual
Est
EPS
$0.06+20.0%
$0.05
Rev
$15M+7.4%
$14M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.02+300.0%
$0.01
Rev
$13M-5.2%
$14M
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$0.06+14.3%
$0.07
Rev
$13M-0.7%
$13M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.08vs $0.03+166.7%
$15Mvs $15M+2.2%
Q2 2026Mar 12, 2026
$0.06vs $0.05+20.0%
$15Mvs $14M+7.4%
Q4 2025Nov 6, 2025
$0.02vs $0.01+300.0%
$13Mvs $14M-5.2%
Q3 2025Aug 7, 2025
$0.06vs $0.07+14.3%
$13Mvs $13M-0.7%
Based on last 12 quarters of dataView full earnings history →

JYNT Peer Comparison

The Joint Corp. (JYNT) competitors in Outpatient clinics and surgery centers — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
XPOF logoXPOFXponential Fitness, Inc.Direct Competitor254.84M6.83-4.65-1.71%-11.1%
SKIN logoSKINThe Beauty Health CompanyDirect Competitor85.9M0.66-4.14-10.02%-2.03%-9.41%6.20
FXNC logoFXNCFirst National CorporationDirect Competitor265.44M29.3614.9827.11%15.35%9.98%0.23
USPH logoUSPHU.S. Physical Therapy, Inc.Product Competitor964.39M63.3244.5916.33%1.52%1.36%0.55
ACHC logoACHCAcadia Healthcare Company, Inc.Product Competitor2.29B24.87-2.055.04%-32.84%-40.92%1.24
ENSG logoENSGThe Ensign Group, Inc.Product Competitor8.98B153.6526.3118.72%6.89%16.61%1.86
ADUS logoADUSAddus HomeCare CorporationProduct Competitor1.76B94.2318.0923.21%6.89%9.34%0.19
UNH logoUNHUnitedHealth Group IncorporatedSupply Chain363.94B400.9630.3111.81%2.68%11.54%0.77

Compare JYNT vs Peers

The Joint Corp. (JYNT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs XPOF

Most directly comparable listed peer for JYNT.

Scale Benchmark

vs UNH

Larger-name benchmark to compare JYNT against a more recognizable public peer.

Peer Set

Compare Top 5

vs XPOF, SKIN, FXNC, USPH

JYNT Income Statement

The Joint Corp. (JYNT) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
25.16M31.79M48.45M58.68M80.01M101.25M46.98M52.16M54.9M56.64M
Revenue Growth %
22.61%26.33%52.41%21.12%36.34%26.55%-53.6%11.04%5.24%221.78%
Cost of Goods Sold
3.31M4.31M5.57M6.51M7.67M9.17M10.48M11.52M11.23M11.37M
COGS % of Revenue
13.16%13.56%11.49%11.09%9.58%9.06%22.31%22.08%20.45%-
Gross Profit
21.85M▲ 0%
27.48M▲ 25.8%
42.88M▲ 56.1%
52.18M▲ 21.7%
72.35M▲ 38.7%
92.08M▲ 27.3%
36.5M▼ 60.4%
40.65M▲ 11.4%
43.67M▲ 7.4%
45.27M▲ 0%
Gross Margin %
86.84%86.44%88.51%88.91%90.42%90.94%77.69%77.92%79.55%79.92%
Gross Profit Growth %
24.27%25.75%56.06%21.66%38.66%27.28%-60.36%11.37%7.44%-
Operating Expenses
24.61M26.68M39.47M46.68M66.22M91.25M36.18M42.54M44.58M44.6M
OpEx % of Revenue
97.79%83.93%81.46%79.55%82.76%90.12%77.01%81.54%81.2%-
Selling, General & Admin
22.59M25.12M37.46M44M62.27M81.95M34.92M41.1M42.93M43.12M
SG&A % of Revenue
89.78%79.03%77.31%74.98%77.83%80.94%74.34%78.79%78.21%-
Research & Development
0343K00000000
R&D % of Revenue
-1.08%--------
Other Operating Expenses
-64.45K-47.77K2.01M2.68M3.95M9.3M1.26M1.44M1.64M1.48M
Operating Income
-3.17M▲ 0%
205.11K▲ 106.5%
3.41M▲ 1564.7%
5.49M▲ 60.8%
6.13M▲ 11.5%
828.25K▼ 86.5%
318.3K▼ 61.6%
-1.89M▼ 693.5%
-905.48K▲ 52.1%
665.64K▲ 0%
Operating Margin %
-12.62%0.65%7.05%9.36%7.66%0.82%0.68%-3.62%-1.65%1.18%
Operating Income Growth %
78.87%106.46%1564.75%60.84%11.54%-86.48%-61.57%-693.48%52.07%-
EBITDA
-1.16M1.76M5.31M8.23M10.05M7.47M8.9M2.83M808.24K2.39M
EBITDA Margin %
-4.6%5.54%10.97%14.02%12.56%7.38%18.95%5.43%1.47%4.22%
EBITDA Growth %
90.71%252.16%201.69%54.81%22.14%-25.61%19.07%-68.17%-71.47%25.58%
D&A (Non-Cash Add-back)
2.02M1.56M1.9M2.73M3.92M6.65M8.58M4.72M1.71M1.72M
EBIT
-2.91M737.5K3.53M5.44M6.15M1.24M297.4K-1.82M-905.48K809.88K
Net Interest Income
00000-820.43K-64.29K280.29K00
Interest Income
00000133.1K0280.29K00
Interest Expense
00000953.53K64.29K000
Other Income/Expense
-64.45K-33.59K-42.22K-79.48K-69.88K-133.1K-64.29K280.29K675.97K711.38K
Pretax Income
-3.24M▲ 0%
215.35K▲ 106.6%
3.37M▲ 1466.0%
5.41M▲ 60.5%
6.06M▲ 11.9%
695.15K▼ 88.5%
254.01K▼ 63.5%
-1.61M▼ 733.3%
-229.5K▲ 85.7%
1.38M▲ 0%
Pretax Margin %
-12.87%0.68%6.96%9.22%7.57%0.69%0.54%-3.08%-0.42%2.43%
Income Tax
35.88K-37.73K48.71K-7.75M-1.51M68.45K11.02M5.61K38.65K36.36K
Effective Tax Rate %
-1.11%-17.52%1.44%-143.27%-24.92%9.85%4339.82%-0.35%-16.84%2.64%
Net Income
-3.28M▲ 0%
253.08K▲ 107.7%
3.32M▲ 1213.3%
13.17M▲ 296.2%
7.57M▼ 42.5%
626.71K▼ 91.7%
-9.75M▼ 1656.1%
-5.8M▲ 40.6%
2.91M▲ 150.2%
3.24M▲ 0%
Net Margin %
-13.02%0.8%6.86%22.44%9.46%0.62%-20.76%-11.11%5.3%5.72%
Net Income Growth %
78.42%107.73%1213.29%296.16%-42.55%-91.72%-1656.11%40.56%150.15%138.06%
Net Income (Continuing)
-3.43M146.7K3.32M13.17M7.57M626.71K-10.77M-1.61M-268.16K1.34M
Discontinued Operations
0000001.02M-4.18M3.18M1.81M
Minority Interest
010010010025K25K25K25K25K25K
EPS (Diluted)
-0.25▲ 0%
0.02▲ 107.2%
0.23▲ 1177.8%
0.90▲ 291.3%
0.44▼ 51.1%
0.04▼ 90.2%
-0.66▼ 1624.2%
-0.39▲ 40.9%
0.19▲ 148.7%
0.23▲ 0%
EPS Growth %
79.17%107.2%1177.78%291.3%-51.11%-90.16%-1624.25%40.91%148.72%138.3%
EPS (Basic)
-0.250.020.240.940.460.04-0.66-0.390.19-
Diluted Shares Outstanding
13.25M14.03M14.47M14.58M14.94M14.87M14.69M15.15M15.13M14.19M
Basic Shares Outstanding
13.2M13.67M13.82M14M14.32M14.49M14.69M14.92M15.13M14.18M
Dividend Payout Ratio
----------

JYNT Balance Sheet

The Joint Corp. (JYNT) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
6.66M11.71M13.3M25.35M26.89M17.61M44.34M74.58M52.09M48.69M
Cash & Short-Term Investments
4.22M8.72M8.46M20.55M19.53M9.75M18.15M25.05M23.6M21.43M
Cash Only
4.22M8.72M8.46M20.55M19.53M9.75M18.15M25.05M23.6M21.43M
Short-Term Investments
0000000000
Accounts Receivable
1.31M955.97K2.77M2.06M3.7M3.91M2.58M2.59M2.85M2.34M
Days Sales Outstanding
19.0110.9820.912.8316.8814.120.0518.118.9517.54
Inventory
587.9K749.13K951.4K0000000
Days Inventory Outstanding
64.7963.4462.39-------
Other Current Assets
602.25K898.74K01.16M1.38M3.96M23.6M46.94M25.64M24.92M
Total Non-Current Assets
10.25M11.82M30.4M40.53M60.17M75.88M42.87M8.58M8.88M9.23M
Property, Plant & Equipment
3.8M3.66M19.07M20.33M32.81M38.06M4.27M3.76M4.73M4.56M
Fixed Asset Turnover
6.62x8.69x2.54x2.89x2.44x2.66x11.00x13.86x11.60x12.04x
Goodwill
2.92M2.92M4.15M4.63M5.09M8.49M7.35M000
Intangible Assets
1.76M1.63M3.22M2.87M4.71M10.93M5.02M000
Long-Term Investments
351.86K128.72K00000000
Other Non-Current Assets
1.78M3.61M3.96M4.77M6.07M6.46M25.19M4.81M4.15M4.68M
Total Assets
16.91M▲ 0%
23.53M▲ 39.1%
43.71M▲ 85.8%
65.88M▲ 50.7%
87.06M▲ 32.2%
93.49M▲ 7.4%
87.21M▼ 6.7%
83.15M▼ 4.6%
60.97M▼ 26.7%
57.92M▲ 0%
Asset Turnover
1.49x1.35x1.11x0.89x0.92x1.08x0.54x0.63x0.90x0.87x
Asset Growth %
-0.85%39.13%85.77%50.73%32.15%7.38%-6.72%-4.65%-26.68%-75.71%
Total Current Liabilities
4.97M8.74M13.57M18.46M21.44M23.22M33.57M49.04M32.82M30.17M
Accounts Payable
1.07M1.25M1.53M1.56M1.71M2.97M1.25M1.75M1.59M961.34K
Days Payables Outstanding
117.77106.13100.0687.5981.22118.0743.6755.4951.6642.83
Short-Term Debt
100K1.1M02.73M0000194.18K280.25K
Deferred Revenue (Current)
2.55M3.36M5.94M6.68M8.43M10.43M2.52M2.55M2.52M10.39M
Other Current Liabilities
3.34M5.88M921.39K955.55K925.72K1.4M27.37M39.2M28.51M24.35M
Current Ratio
1.34x1.34x0.98x1.37x1.25x0.76x1.32x1.52x1.59x1.61x
Quick Ratio
1.22x1.25x0.91x1.37x1.25x0.76x1.32x1.52x1.59x1.61x
Cash Conversion Cycle
-33.97-31.72-16.77-------25.29
Total Non-Current Liabilities
7.04M12.43M24.42M26.3M35.31M37.69M28.86M13.43M13.07M12.26M
Long-Term Debt
1M002M2M2M2M000
Capital Lease Obligations
0011.94M10.77M16.96M18.74M448.31K311.69K1.82M7.46M
Deferred Tax Liabilities
136.43K76.67K89.86K00057.15K000
Other Non-Current Liabilities
1.21M1.11M27.23K27.23K3.4M2.79M12.76M672.33K0286.77K
Total Liabilities
12.01M21.17M37.99M44.75M56.75M60.9M62.44M62.48M45.89M42.43M
Total Debt
1.1M1.1M14.27M18.48M23.62M26.06M2.86M795.03K2.01M2.04M
Net Debt
-3.12M-7.62M5.82M-2.07M4.1M16.31M-15.29M-24.26M-21.59M-19.38M
Debt / Equity
0.22x0.47x2.50x0.87x0.78x0.80x0.12x0.04x0.13x0.13x
Debt / EBITDA
-0.62x2.69x2.25x2.35x3.49x0.32x0.28x2.49x0.86x
Net Debt / EBITDA
--4.32x1.09x-0.25x0.41x2.18x-1.72x-8.56x-26.71x-8.12x
Interest Coverage
-----1.30x4.63x---
Total Equity
4.9M▲ 0%
2.36M▼ 51.8%
5.72M▲ 142.3%
21.13M▲ 269.3%
30.31M▲ 43.5%
32.59M▲ 7.5%
24.77M▼ 24.0%
20.68M▼ 16.5%
15.08M▼ 27.1%
15.49M▲ 0%
Equity Growth %
-29.26%-51.8%142.26%269.31%43.46%7.52%-23.98%-16.53%-27.07%-38.17%
Book Value per Share
0.370.170.401.452.032.191.691.371.001.09
Total Shareholders' Equity
4.9M2.36M5.72M21.13M30.28M32.56M24.75M20.65M15.05M15.47M
Common Stock
13.6K13.76K13.9K14.17K14.45K14.56K14.78K15.19K15.47K15.74K
Retained Earnings
-32.26M-35.75M-33.64M-20.09M-12.78M-12.15M-21.91M-27.7M-24.8M-23.5M
Treasury Stock
-86.05K-90.86K-111.04K-143.11K-850.84K-856.64K-860.48K-870.06K-12.19M-13.39M
Accumulated OCI
-3.93M-4.91M00000000
Minority Interest
010010010025K25K25K25K25K25K

JYNT Cash Flow Statement

The Joint Corp. (JYNT) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
156.44K5.45M7.52M11.18M13.84M8.21M14.68M9.42M1.84M4.06M
Operating CF Margin %
0.62%17.15%15.52%19.06%17.3%8.11%31.24%18.05%3.35%-
Operating CF Growth %
101.44%3385.12%37.96%48.67%23.79%-40.7%78.79%-35.85%-80.47%170.92%
Net Income
-3.28M253.08K3.32M13.17M7.57M626.71K-9.75M-8.53M2.91M3.24M
Depreciation & Amortization
2.02M1.56M1.9M2.73M3.92M6.65M8.58M4.72M1.71M1.71M
Stock-Based Compensation
594.37K628.43K720.65K885.98K1.06M1.27M1.74M1.68M1.3M657.28K
Deferred Taxes
15.73K-77.02K1.78K0-1.78M010.9M-55.56K93.07K93.07K
Other Non-Cash Items
423.72K308.98K-18.89K-6.04M-7.77K3.61M2.41M10.5M5.39M6.11M
Working Capital Changes
380.52K2.78M1.6M433.24K3.09M-3.95M798.62K1.1M-9.56M-6.82M
Change in Receivables
-124.11K-75.33K-1.84M794.59K-1.64M-154.67K192.35K-1.65M1.53M532.37K
Change in Inventory
-718.64K1.11M3.39M0000000
Change in Payables
-36.75K63.57K75.89K0-14.37K0-1.38M68.26K-391.13K-588.3K
Cash from Investing
-372.85K-1.24M-7.14M-4.6M-12.75M-17.9M-6.19M-631.55K6.27M6.33M
Capital Expenditures
-449.2K-1.39M-4.17M-3.16M-6.99M-5.9M-5M-1.19M-1.5M-1.41M
CapEx % of Revenue
1.79%4.37%8.6%5.38%8.74%5.83%10.64%2.27%2.74%2.48%
Acquisitions
0-100K-3.12M-534K-5.77M-12.11M-1.19M554.1K7.78M7.78M
Investments
----------
Other Investing
76.35K245.71K149.35K-910.78K0105.2K000-40.1K
Cash from Financing
1.42M326.3K-596.96K5.6M-2M328.61K174.12K-2M-9.81M-11.87M
Debt Issued (Net)
768.5K0-1.12M1.89M-2.81M-49.85K-24.43K-2.03M-4.35K0
Equity Issued (Net)
292.67K0-20.18K-32.07K0-5.8K198.55K24.13K-9.8M-11.87M
Dividends Paid
0000000000
Share Repurchases
-2.65K-4.81K-20.18K-32.07K0-5.8K-3.83K-9.58K-11.32M-12.52M
Other Financing
361.6K326.3K545.18K3.74M811.59K384.27K0000
Net Change in Cash
1.21M▲ 0%
4.53M▲ 275.9%
-213.07K▼ 104.7%
12.18M▲ 5815.2%
-907.29K▼ 107.5%
-9.36M▼ 931.9%
8.66M▲ 192.5%
6.78M▼ 21.7%
-1.69M▼ 125.0%
-1.47M▲ 0%
Free Cash Flow
-292.76K▲ 0%
4.06M▲ 1487.8%
3.36M▼ 17.4%
8.03M▲ 139.1%
6.85M▼ 14.6%
2.31M▼ 66.3%
9.68M▲ 318.9%
8.23M▼ 15.0%
334.72K▼ 95.9%
2.66M▲ 0%
FCF Margin %
-1.16%12.78%6.93%13.68%8.57%2.28%20.6%15.78%0.61%4.69%
FCF Growth %
97.7%1487.79%-17.38%139.12%-14.61%-66.29%318.89%-14.97%-95.93%49.06%
FCF per Share
-0.020.290.230.550.460.160.660.540.020.19
FCF Conversion (FCF/Net Income)
-0.05x21.54x2.26x0.85x1.83x13.10x-1.51x-1.62x0.63x0.82x
Interest Paid
108.02K0042.83K071.25K173.06K69.44K012.64K
Taxes Paid
29.32K00000569.76K610.49K00

JYNT Key Ratios

The Joint Corp. (JYNT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-55.4%6.97%82.25%98.09%29.42%1.99%-34%-25.51%16.26%16.92%
Return on Invested Capital (ROIC)
-78.98%-81.54%26.93%17.19%1.49%0.82%-48.02%--9.66%
Gross Margin
86.84%86.44%88.51%88.91%90.42%90.94%77.69%77.92%79.55%79.92%
Net Margin
-13.02%0.8%6.86%22.44%9.46%0.62%-20.76%-11.11%5.3%5.72%
Debt / Equity
0.22x0.47x2.50x0.87x0.78x0.80x0.12x0.04x0.13x0.13x
Interest Coverage
-----1.30x4.63x---
FCF Conversion
-0.05x21.54x2.26x0.85x1.83x13.10x-1.51x-1.62x0.63x0.82x
Revenue Growth
22.61%26.33%52.41%21.12%36.34%26.55%-53.6%11.04%5.24%221.78%
Related:JYNT Dividend History·JYNT Revenue History·JYNT Price History·JYNT P/E History·JYNT Financial Ratios·JYNT Institutional Holders

JYNT SEC Filings & Documents

The Joint Corp. (JYNT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

May 1, 2026·SEC

Material company update

Apr 24, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 13, 2026·SEC

FY 2025

Mar 14, 2025·SEC

FY 2024

Mar 8, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 8, 2026·SEC

FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 12, 2025·SEC

JYNT Frequently Asked Questions

The Joint Corp. (JYNT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

The Joint Corp. (JYNT) reported $56.6M in revenue for fiscal year 2025. This represents a 1934% increase from $2.8M in 2012.

The Joint Corp. (JYNT) grew revenue by 5.2% over the past year. This is steady growth.

Yes, The Joint Corp. (JYNT) is profitable, generating $3.2M in net income for fiscal year 2025 (5.3% net margin).

Dividend & Returns

The Joint Corp. (JYNT) has a return on equity (ROE) of 16.3%. This is reasonable for most industries.

The Joint Corp. (JYNT) generated $2.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in JYNT back in 2012?

Total return calculator · dividends reinvested · 14+ years of data

See returns →

How much would $100/month in JYNT be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →